Early market potential and pricing assessment for the life-science industry
We support life-science companies in assessing the commercial opportunity, pricing potential, and reimbursement outlook for their assets.
We evaluate the commercial potential of pharmaceutical products, with a focus on market sizing, pricing, and reimbursement outlook. Our work combines quantitative expertise in economic and financial modelling, statistics, and data analytics with a strong understanding of market access and payer dynamics. By integrating technical analyses into broader commercial and strategic thinking, we help clients generate relevant evidence, challenge key assumptions, and make more informed product development decisions from an early stage.
Building the basis for future P&R success
By integrating commercial and market access considerations from the outset, we aim to shape product development today to support stronger pricing and reimbursement outcomes tomorrow.
Solid quantitative expertise combined with business-oriented thinking
We can seamlessly integrate technical analyses into broader commercial and strategic projects, combining quantitative expertise with a comprehensive understanding of market dynamics.
Large network of advisors and payer experts
We have long-standing collaborations with multiple advisors across Europe and North America, giving access to a broad range of expertise tailored to different project needs.
Our backgrounds reflect extensive experience in the healthcare and life sciences sectors, spanning economic evaluation, financial modelling, and international pricing and market access.
Lorenzo Celico
Lorenzo is Managing Director of C2 Health Consulting. His core expertise lies in assessing the economic and financial value of innovative drug products. He has over 10 years of experience in the healthcare and biotech sectors, with expertise in pharmacoeconomics, budget impact modelling, and financial forecasting. He graduated in Economics from the University of Zurich.
Gianluca Furneri
Gianluca is Senior Advisor at C2 Health Consulting. He brings over 20 years of experience in the healthcare and life-science sectors and has led more than 50 international pricing and market access projects. Through his work, he has developed a strong global network of payer experts. Previously, he founded and led a boutique life-science consulting firm.
